The time it takes to create a database is also significant and continues to grow as we adopt virtual research practices. Research participants may now choose to submit data from their cell phone, a home computer, or via an iPad provided during an on-site clinic visit. These new approaches require study teams to consistently embrace new technology as well keep pace with ever-changing data security and privacy considerations.

Diane M. Harper MD, MPH, MS, will serve as the faculty lead of the new Hub Research Capacity Core at MICHR. The Hub Research Capacity Core represents the integration of critical components of ensuring implementation of high-quality clinical research at the University of Michigan.

Researchers at Michigan Medicine have teamed up to launch a study to test the safety and efficacy of the agent defibrotide to treat patients with COVID-19 illnesses.

Dr. Byrd is part of a multi-site study that is evaluating whether continuing medication versus discontinuing common blood pressure medications (ACE inhibitors or angiotensin receptor blockers) at time of hospitalization for COVID-19 makes a difference in how people recover and respond to treatment, focusing on two of the most common blood pressure treatments in the U.S.

The Children’s Neurodevelopmental Assessment Core (C-NAC) is available to all investigators who are planning to conduct pediatric research (ages birth to 22 years) that requires surveys or direct assessment of development, cognition, quality of life, adaptive functioning, and mental health.